These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27366899)

  • 21. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells.
    Idres N; Marill J; Chabot GG
    Biochem Pharmacol; 2005 Jun; 69(11):1595-601. PubMed ID: 15896339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.
    Topletz AR; Tripathy S; Foti RS; Shimshoni JA; Nelson WL; Isoherranen N
    Mol Pharmacol; 2015; 87(3):430-41. PubMed ID: 25492813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding.
    Gomaa MS; Yee SW; Milbourne CE; Barbera MC; Simons C; Brancale A
    J Enzyme Inhib Med Chem; 2006 Aug; 21(4):361-9. PubMed ID: 17059167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
    Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid.
    Langton S; Gudas LJ
    Dev Biol; 2008 Mar; 315(2):331-54. PubMed ID: 18241852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.
    Diaz P; Huang W; Keyari CM; Buttrick B; Price L; Guilloteau N; Tripathy S; Sperandio VG; Fronczek FR; Astruc-Diaz F; Isoherranen N
    J Med Chem; 2016 Mar; 59(6):2579-95. PubMed ID: 26918322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the cytochrome P-450 modulates all-trans-retinoic acid-induced differentiation and apoptosis of HL-60 cells.
    Hofmanová J; Soucek K; Dusek L; Netíková J; Kozubík A
    Cancer Detect Prev; 2000; 24(4):325-42. PubMed ID: 11059564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.
    Liu W; Lee HW; Liu Y; Wang R; Rodgers GP
    Blood; 2010 Dec; 116(23):4938-47. PubMed ID: 20724538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three conazoles increase hepatic microsomal retinoic acid metabolism and decrease mouse hepatic retinoic acid levels in vivo.
    Chen PJ; Padgett WT; Moore T; Winnik W; Lambert GR; Thai SF; Hester SD; Nesnow S
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):143-55. PubMed ID: 19010342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis.
    Xia L; Wurmbach E; Waxman S; Jing Y
    Leukemia; 2006 Jun; 20(6):1009-16. PubMed ID: 16572199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid.
    Taimi M; Helvig C; Wisniewski J; Ramshaw H; White J; Amad M; Korczak B; Petkovich M
    J Biol Chem; 2004 Jan; 279(1):77-85. PubMed ID: 14532297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
    Njar VC; Gediya L; Purushottamachar P; Chopra P; Vasaitis TS; Khandelwal A; Mehta J; Huynh C; Belosay A; Patel J
    Bioorg Med Chem; 2006 Jul; 14(13):4323-40. PubMed ID: 16530416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the
    Stevison F; Hogarth C; Tripathy S; Kent T; Isoherranen N
    Drug Metab Dispos; 2017 Jul; 45(7):846-854. PubMed ID: 28446509
    [No Abstract]   [Full Text] [Related]  

  • 34. Stereoselective formation and metabolism of 4-hydroxy-retinoic Acid enantiomers by cytochrome p450 enzymes.
    Shimshoni JA; Roberts AG; Scian M; Topletz AR; Blankert SA; Halpert JR; Nelson WL; Isoherranen N
    J Biol Chem; 2012 Dec; 287(50):42223-32. PubMed ID: 23071109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases.
    Topletz AR; Thatcher JE; Zelter A; Lutz JD; Tay S; Nelson WL; Isoherranen N
    Biochem Pharmacol; 2012 Jan; 83(1):149-63. PubMed ID: 22020119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
    Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
    J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells.
    Huang S; Shen Q; Mao WG; Li AP; Ye J; Liu QZ; Zou CP; Zhou JW
    J Biomed Sci; 2006 May; 13(3):357-71. PubMed ID: 16468075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
    Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
    Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy.
    Njar VC
    Mini Rev Med Chem; 2002 Jun; 2(3):261-9. PubMed ID: 12370067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.